Epidermal Growth Factor Receptor | | Target | Target | Xaa-Pro Dipeptidase | | | | | | |
Platelet Aggregation | | Disease | Drug | Alprostadil for Injection (Edex)- FDA | | | | | | |
Platelet Aggregation | | Disease | Drug | Alprostadil Injection (Caverject)- FDA | | | | | | |
CD4 | | Target | Target | CTLA-4/Fc | | | | | | |
Cervical Cancer | | Disease | Target | Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 | | | | | | |
Infectious Diseases | | Disease | Target | CCBL1 | | | | | | |
Meningitis | | Disease | Target | CCBL1 | | | | | | |
CD4 | | Target | Target | Ck-beta-11 | | | | | | |
Prostate Cancer | | Disease | Target | Egl Nine Homolog 1 | | | | | | |
Prostate Cancer | | Disease | Drug | Ancobon (Flucytosine)- FDA | | | | | | |
Hemorrhage | | Disease | Drug | Alprostadil for Injection (Edex)- FDA | | | | | | |
Hemorrhage | | Disease | Drug | Alprostadil Injection (Caverject)- FDA | | | | | | |
Shock | | Disease | Target | Xaa-Pro Dipeptidase | | | | | | |
Stroke | | Disease | Drug | Alprostadil Injection (Caverject)- FDA | | | | | | |
Stroke | | Disease | Target | E-Selectin/CD62E | | | | | | |
Stroke | | Disease | Target | Melatonin Receptor Type 1a | | | | | | |
Depression | | Disease | Target | Melatonin Receptor Type 1a | | | | | | |
Diabetes | | Disease | Target | Xaa-Pro Dipeptidase | | | | | | |
Diabetes | | Disease | Target | E-Selectin/CD62E | | | | | | |
Cancer | | Disease | Target | Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 | | | | | | |
Carcinoma | | Disease | Target | Xaa-Pro Dipeptidase | | | | | | |
Carcinoma | | Disease | Target | Egl Nine Homolog 1 | | | | | | |
Carcinoma | | Disease | Target | CCBL1 | | | | | | |
Cancer | | Disease | Drug | Drimenin | | | | | | |
Infection | | Disease | Target | CCBL1 | | | | | | |
Cancer | | Disease | Drug | Acarbose (Precose)- FDA | | | | | | |
Cancer | | Disease | Target | Ck-beta-11 | | | | | | |
Cancer | | Disease | Target | Xaa-Pro Dipeptidase | | | | | | |
Cancer | | Disease | Target | Egl Nine Homolog 1 | | | | | | |
Cancer | | Disease | Drug | Ancobon (Flucytosine)- FDA | | | | | | |
Cancer | | Disease | Target | Melatonin Receptor Type 1a | | | | | | |
Cancer | | Disease | Target | CCBL1 | | | | | | |
Anagrelide (Agrylin)- FDA | | Drug | Drug | Agrylin (Anagrelide)- FDA | | | | | | |
Almotriptan Malate (Axert)- FDA | | Drug | Drug | Amerge (Naratriptan)- FDA | | | | | | |
Axert (Almotriptan Malate)- FDA | | Drug | Drug | Amerge (Naratriptan)- FDA | | | | | | |
Axid Oral Solution (Nizatidine)- FDA | | Drug | Drug | Axid (Nizatidine)- FDA | | | | | | |
Arimidex (Anastrozole)- FDA | | Drug | Drug | Aminoglutethimide (Cytadren)- FDA | | | | | | |
Anidulafungin (Eraxis)- FDA | | Drug | Drug | Altabax (Retapamulin)- FDA | | | | | | |
Alosetron Hydrochloride (Lotronex)- FDA | | Drug | Drug | Amerge (Naratriptan)- FDA | | | | | | |
Artemin | | Target | Target | Enovin | | | | | | |
Fabry Disease | | Disease | Drug | Agalsidase Beta (Fabrazyme)- FDA | | | | | | |
Rare Diseases | | Disease | Drug | Agrylin (Anagrelide)- FDA | | | | | | |
Thromboembolic Disease | | Disease | Drug | Aygestin (Norethindrone)- FDA | | | | | | |
Heartburn | | Disease | Drug | Axid (Nizatidine)- FDA | | | | | | |
Gout | | Disease | Drug | Anturane (Sulfinpyrazone)- FDA | | | | | | |
Xanthine Oxidase | | Target | Drug | Anturane (Sulfinpyrazone)- FDA | | | | | | |
Gastroesophageal Reflux Disease | | Disease | Drug | Axid (Nizatidine)- FDA | | | | | | |
Multiple Myeloma | | Disease | Drug | Alkeran (Melphalan)- FDA | | | | | | |
Metastatic Breast Cancer | | Disease | Drug | Aminoglutethimide (Cytadren)- FDA | | | | | | |
Glucocorticoid Receptor | | Target | Drug | Aminoglutethimide (Cytadren)- FDA | | | | | | |